1. Definitions. As used in this section, unless the context otherwise indicates, the following terms have the following meanings.
A. “Insulin” includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation. [PL 2019, c. 666, Pt. B, §1 (NEW).]
B. “Insulin-related devices and supplies” means needles, syringes, cartridge systems, prefilled pen systems, glucose meters and test strips. “Insulin-related devices and supplies” does not include insulin pump devices. [PL 2019, c. 666, Pt. B, §1 (NEW).]

[PL 2019, c. 666, Pt. B, §1 (NEW).]

Terms Used In Maine Revised Statutes Title 32 Sec. 13786-D

  • Board: means the Maine Board of Pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Collaborative practice agreement: means a written and signed agreement between one or more pharmacists with training and experience relevant to the scope of the collaborative practice and a practitioner that supervises or provides direct consultation to the pharmacist or pharmacists engaging in collaborative drug therapy management that:
A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Drug: means :
    • A. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Evidence: Information presented in testimony or in documents that is used to persuade the fact finder (judge or jury) to decide the case for one side or the other.
  • Pharmacist: means an individual provider of health care services licensed by this State to engage in the practice of pharmacy. See Maine Revised Statutes Title 32 Sec. 13702-A
  • Practitioner: means an individual who is licensed, registered or otherwise authorized in the appropriate jurisdiction to prescribe and administer drugs in the course of professional practice. See Maine Revised Statutes Title 32 Sec. 13702-A
    • 2. Authorization. As authorized by the board in accordance with rules adopted under subsection 3, a pharmacist may dispense emergency refills of insulin and associated insulin-related devices and supplies by prescription drug order or standing order or pursuant to a collaborative practice agreement authorizing insulin to be dispensed. The insulin dispensed under this subsection must be in a quantity that is at least a 30-day supply unless the intended recipient requests a lesser quantity upon consultation with the pharmacist. The intended recipient shall provide evidence of a previous prescription from a practitioner and attest that a refill of that previous prescription may not be readily or easily obtained under the circumstances. Upon receiving evidence of a previous prescription from a practitioner, the pharmacist shall immediately notify that practitioner that an emergency refill of insulin was dispensed and instruct the recipient to seek follow-up care from the practitioner as soon as possible.

    [PL 2021, c. 20, §1 (AMD).]

    3. Rules; protocols. The board by rule shall establish standards for authorizing pharmacists to dispense insulin in accordance with subsection 2, including protocols for notifying practitioners when emergency refills of insulin are dispensed. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2?A.

    [PL 2021, c. 20, §2 (AMD).]

    SECTION HISTORY

    PL 2019, c. 666, Pt. B, §1 (NEW). PL 2021, c. 20, §§1, 2 (AMD).
      Previous section
    Next section  
     Subchapter 9 Contents